The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Block of hERG $K^+$ Channel by Classic Histamine $H_1$ Receptor Antagonist Chlorpheniramine

  • Hong, Hee-Kyung (Department of Physiology, Institute of Bioscience and Biotechnology, Kangwon National University College of Medicine) ;
  • Jo, Su-Hyun (Department of Physiology, Institute of Bioscience and Biotechnology, Kangwon National University College of Medicine)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Chlorpheniramine is a potent first-generation histamine $H_1$ receptor antagonist that can increase action potential duration and induce QT prolongation in several animal models. Since block of cardiac human ether-a-go-go-related gene (hERG) channels is one of leading causes of acquired long QT syndrome, we investigated the acute effects of chlorpheniramine on hERG channels to determine the electrophysiological basis for its proarrhythmic potential. We examined the effects of chlorpheniramine on the hERG channels expressed in Xenopus oocytes using two-microelectrode voltage-clamp techniques. Chlorpheniramine induced a concentration-dependent decrease of the current amplitude at the end of the voltage steps and hERG tail currents. The $IC_{50}$ of chlorpheniramine-dependent hERG block in Xenopus oocytes decreased progressively relative to the degree of depolarization. Chlorpheniramine affected the channels in the activated and inactivated states but not in the closed states. The S6 domain mutations Y652A and F656A partially attenuated (Y652A) or abolished (F656A) the hERG current block. These results suggest that the $H_1$ antihistamine, chlorpheniramine is a blocker of the hERG channels, providing a molecular mechanism for the drug-induced arrhythmogenic side effects.

Keywords

References

  1. Arcangeli A, Becchetti A, Mannini A, Mugnai G, De Pilippi P, Tarone G, Del Bene MR, Barletta E, Wanke E, Olivotto M. Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J Cell Biol 122: 1131−1143, 1993 https://doi.org/10.1083/jcb.122.5.1131
  2. Arcangeli A, BIanchi L, Becchetti A, Faravelli L, Coronnello M, Mini E, Olivotto M, Wanke E. A novel inward-rectifier K＋ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol (Lond) 489: 455−471, 1995
  3. Baselt R, Cravey R. Disposition of toxic drugs and chemicals in man. 4th ed. Foster City, CA: Chemical Toxicology Institute, 1995
  4. Chiesa N, Rosati B, Arcangeli A, Olivotto M, Wanke E. A novel role for HERG $K^+$ channels: spike-frequency adaptation. J Physiol (Lond) 501: 313−318, 1997 https://doi.org/10.1111/j.1469-7793.1997.313bn.x
  5. Choi SY, Koh YS, Jo SH. Inhibition of human ether-a-go-go-related gene $K^+$ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine. J Pharmacol Exp Ther 313: 888−895, 2005
  6. Craft TM. Torsade de pointes after astemizole overdose. Br Med J 292: 60, 1986
  7. Goldberg MJ, Spector R, Chiang CK. Transport of diphenhydra mine in the central nervous system. J Pharmacol Exp Ther 240: 717−722, 1987
  8. Hestand HE, Teske DW. Diphenhydramine hydrochloride intoxication. J Pediatr 90: 1017−1018, 1977 https://doi.org/10.1016/S0022-3476(77)80586-6
  9. Huang SM, Chiou WL. Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration. J Pharmacokinet Biopharm 9: 711−723, 1981 https://doi.org/10.1007/BF01070902
  10. Hung YM, Chang JC. Weight-reducing regimen associated with polymorphic ventricular tachycardia. Am J Emerg Med 24: 714−716, 2006 https://doi.org/10.1016/j.ajem.2006.02.004
  11. Katzung BG. Histamine, Serotonin, and the ergot alkaloids. Basic and Clinical Pharmacology, 9th ed, McGraw-Hill, San Francisco, p263−268, 2003
  12. Ki I, Inui A, Ito T. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles. Arch Int Pharmacodyn Ther 331: 59−73, 1996
  13. Mitcheson JS. Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine. Br J Pharmacol 139: 883−884, 2003 https://doi.org/10.1038/sj.bjp.0705336
  14. Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97: 12329−12333, 2000 https://doi.org/10.1073/pnas.210244497
  15. Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 58: 32−45, 2003 https://doi.org/10.1016/S0008-6363(02)00846-5
  16. Reed D. A fatal case involving chlorpheniramine. Clin Toxicol 18: 941−943, 1981 https://doi.org/10.3109/15563658108990322
  17. Sànchez-Chapula JA, Navarro-Polanco RA, Culberson C, Chen J, Sanguinetti MC. Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) $K^+$ channel block. J Biol Chem 277: 23587−23595, 2002 https://doi.org/10.1074/jbc.M200448200
  18. Suessbrich H, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 385: 77−80, 1996 https://doi.org/10.1016/0014-5793(96)00355-9
  19. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Fujii T, Komemushi S, Itoh M, Sasaki H, Watanabe T, Yanai K. Differential cognitive effects of ebastine and (＋)- chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration. Br J Clin Pharmacol 53: 296−304, 2002 https://doi.org/10.1046/j.0306-5251.2001.01183.x
  20. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S, Ido T, Itoh M, Sasaki H, Watanabe T, Yanai K. Neuroimaging of histamine H1- receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second- generation antihistamine, and (＋)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol 52: 501−509, 2001 https://doi.org/10.1046/j.1365-2125.2001.01471.x
  21. Taglialatela M, Castaldo P, Pannaccione A, Giorgio G, Genovese A, Marone G, Annunziato L. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity, Clin Exp Allergy 29: 182−189, 1999
  22. Taglialatela M, Timmerman H, Annunziato L. Cardiotoxic potential and CNS effects of first-generation antihistamines. Trends Pharmacol Sci 21: 52−56, 2000 https://doi.org/10.1016/S0165-6147(99)01437-6
  23. Tie H, Walker BD, Valenzuela SM, Breit SN, Campbell TJ. The heart of psychotropic drug therapy. Lancet 355: 1825, 2000
  24. Venkatraman N, O'Neil D, Hall AP. Life-threatening overdose with lamotrigine, citalopram, and chlorpheniramine. J Postgrad Med 54: 316−317, 2008 https://doi.org/10.4103/0022-3859.43516
  25. Wymore RS, Gintant GA, Wymore RT, Dixon JE, Mckinnon D, Cohen IS. Tissue and species distribution of mRNA for the IKr-like K＋ channel, erg. Circ Res 80: 261−268, 1996
  26. Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74: 230−241, 1998 https://doi.org/10.1016/S0006-3495(98)77782-3